| CPT |
Report |
Q2 Core FFO / share |
BEAT |
pred ~$1.69 vs. cons $1.67 |
MEDIUM |
| CPT |
Report |
Q2 same-store revenue growth (YoY) |
IN-LINE |
pred ~+1.0% vs. cons +0.8% |
MEDIUM |
| CPT |
Report |
Q2 same-store NOI growth (YoY) |
BEAT |
pred ~-0.1% vs. cons -0.6% |
LOW |
| CPT |
Guide |
FY2026 Core FFO guidance (midpoint) |
BETTER |
guide ~$6.78 vs. cons $6.75 (FY2026) |
LOW |
| CPT |
Guide |
FY2026 same-store revenue guidance |
UNCHANGED |
guide ~+0.75% vs. cons +0.8% (FY2026) |
MEDIUM |
| CPT |
Guide |
Q3 2026 Core FFO guidance |
UNCHANGED |
guide ~$1.70 vs. cons $1.70 (Q3 2026) |
LOW |
| CPT |
Guide |
California portfolio disposition close/price |
UNKNOWN |
pred close ~$1.0B at ~5.0% cap vs. expected ~$1.0B (2Q/3Q26) |
MEDIUM |
| CPT |
Return |
Day-1 residual (stock − beta × S&P 500) |
+0.8% |
— |
MEDIUM |
| CPT |
Return |
5-day cumulative residual |
-0.3% (FADE) |
A modest, largely pre-announced Core FFO beat leaning on timing/bad-debt tailwinds plus at-best a token FY midpoint raise gives a small positive day-1 pop, but out-period math works against follow-through: skepticism on the 2H 'hockey-stick' blended-rate ramp, Sunbelt oversupply still being digested (coastal peers outrunning the Sunbelt), Houston softness, and 1031/California-sale timing variability cause estimates to drift and the initial gain to fade back toward flat over 5 days. |
MEDIUM |